Navigation Links
Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission
Date:5/21/2008

Three of Four HUMIRA Patients from CHARM Study in Remission at One Year

Maintained Remission at Two Years

ABBOTT PARK, Ill., May 21 /PRNewswire-FirstCall/ -- Results from an open-label extension study of two Abbott pivotal studies, CHARM and GAIN, demonstrate that adult moderate-to-severe Crohn's patients treated with HUMIRA(R) (adalimumab) achieved long-term clinical remission and clinical response, respectively, according to data presentations today at Digestive Disease Week(R) (DDW) in San Diego. DDW is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery. Patients from CHARM and GAIN were followed through into a non-placebo controlled, ongoing open-label extension (OLE) trial. Patients from CHARM were followed a total of two years, and patients from the 4-week GAIN study were followed a total of one year.

The CHARM extension data demonstrated that three out of four patients (77 percent) taking HUMIRA, who were in remission at the end of the one-year pivotal study, maintained clinical remission for an additional year. The GAIN data showed that, of patients with a clinical response at four weeks, approximately 65 percent remained in clinical response at one year, and 40 percent were in clinical remission at one year. Response was measured by change in Crohn's Disease Activity Index (CDAI), a weighted composite score of eight clinical factors that evaluate patient wellness, including daily number of liquid or very soft stools, severity of abdominal pain, levels of general well-being and other measures. Clinical remission was measured as a score of less than 150 and clinical response was measured as a decline of at least 70 points from baseline.

Crohn's disease is a serious, chronic, inflammatory bowel disease that affects more than 500,000 Americans. It affects people of all ages but it is primarily a disease
'/>"/>

SOURCE Abbott
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years
2. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
3. Abbotts Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL
4. Abbotts XIENCE(TM) V Drug Eluting Stent Demonstrates Consistent and Positive Clinical Outcomes Out to Two Years
5. Abbotts HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis
6. Abbotts m2000(TM) Molecular Diagnostic Instrument and RealTime HIV-1 Test Win Chicago Innovation Award
7. Abbott Announces Positive One-Year Results from the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
8. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
9. Abbotts ABT-874 Shows Positive Results for Maintenance of Response in Phase II Psoriasis Study
10. Abbott Initiates Clinical Study to Evaluate Use of RX Herculink(R) Elite(TM) Renal Stent System for the Treatment of Renal Artery Stenosis
11. Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... and BRIDGEWATER, N.J. , ... REGN) and Sanofi US (EURONEXT: SAN and NYSE: SNY) ... organizations to launch Cholesterol Counts , an awareness ... cholesterol, their numbers, and the risks associated with high ... www. CholesterolCounts .com to take a brief ...
(Date:12/15/2014)... Texas , Dec. 15, 2014  Stephen Squires, ... manufacturer Quantum Materials Corp (OTCQB:QTMM), will be ... for Quantum Materials (RCQM) on December 16th, 2014. The ... of exotic nanomaterials in attracting top faculty and students ... to collaborate on research. "We have ...
(Date:12/14/2014)... S.C. , Dec. 14, 2014  ChartSpan, a ... the most downloaded iPhone and iPad medical app in ... Photo - http://photos.prnewswire.com/prnh/20141214/164317 ChartSpan ... the ability to request, manage and send electronic healthcare ... innovative entrepreneurs who grew tired of waiting for the ...
Breaking Medicine Technology:Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 2Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 3Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 4Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 5Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 6Quantum Materials CEO Stephen Squires to Speak at Rice Center for Quantum Materials Launch 2Quantum Materials CEO Stephen Squires to Speak at Rice Center for Quantum Materials Launch 3ChartSpan Becomes The Most Downloaded Medical App in America 2ChartSpan Becomes The Most Downloaded Medical App in America 3
... the U.S. Department of Health and Human Services (HHS) ... flexible benefits in the exchanges, the Institute of Medicine ... some powerful special interests that benefit from costly new ... A new survey shows ...
... U.S. Food and Drug Administration and the Centers for ... review" pilot program for concurrent review of medical devices ... (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) The FDA ... procedures for voluntary participation and guiding principles that the ...
Cached Medicine Technology:PCMA on IOM Essential Health Benefits Report: Employers and Special Interests Will Spar Over Costly Prescription Drug Mandates 2FDA, CMS Launch Pilot Program for Voluntary Parallel Review of Innovative Devices 2
(Date:12/17/2014)... 16, 2014 (HealthDay News) -- Expectant parents should leave ... Drug Administration recommends. Use of ultrasound imaging and ... not entirely risk-free, the agency warns. "Although ... due to ultrasound imaging and heartbeat monitors, prudent use ... important," Shahram Vaezy, an FDA biomedical engineer, said in ...
(Date:12/17/2014)... Kathleen Doheny HealthDay Reporter ... sleep loss is rampant in America, and work commitment is ... the No. 1 sleep killer," said Dr. Mathias Basner, an ... University of Pennsylvania Perelman School of Medicine. A time-use ... found that work is the main activity exchanged for sleep. ...
(Date:12/15/2014)... FL (PRWEB) December 15, 2014 South Florida’s ... knows that holidays can be a daze of hassle, hustle, ... and falls while decking halls, to burns when making special ... holiday hazards that can happen at any time. To prevent ... MD Now has made a list of helpful and healthful ...
(Date:12/15/2014)... -- Expert pilots process visual information more efficiently than ... decisions during landings, a new study shows. Landing ... to master, and 36 percent of all airplane crashes ... approach and landing. Researchers monitored the brain activity ... while they were at the controls of a flight ...
(Date:12/15/2014)... Los Angeles, CA (PRWEB) December 15, 2014 ... advocacy arena, the organizations AutismOne and ... who will enlighten attendees with research on the effects ... objective laboratory testing and intervention information. , Luminaries ... join additional researchers from abroad with esteemed, credentialed colleagues ...
Breaking Medicine News(10 mins):Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Study Shows Why Expert Pilots Are Experts 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3
... both conditions, study finds , , MONDAY, June 30 (HealthDay ... development of high blood pressure, diabetes and immune problems, researchers ... the body, clipping off working segments of the receptors that ... to a report in the June 30 online issue of ...
... care organizations , ... ROUND ROCK, Texas (Business Wire ... today operate under the mantra that ,more is better, when it ... Health Care and Life Sciences. "Virtualizing the IT infrastructure fully illustrates ...
... Convene in Chicago, August 2-3, CHICAGO, June ... everything,in between, dermatology nurses and related professionals play ... their patients., The Dermatology Nurses, Association (DNA) ... variety of learning formats and,the profession,s best networking ...
... The American Heart,Association has set August for the ... of six new titles to be published,under the banner ... will be published by Lippincott Williams & Wilkins, a ... has been named editor of the new journal. Faxon,is ...
... support surface products to be included as part of company,s, ... ... preventing pressure ulcers, MUNDELEIN, Ill., June 30 ... pressure redistribution,mattresses, operating room table pads and stretcher pads aimed ...
... the development, marketing and sale of proprietary, patent-pending nutraceutical products, including ... is launching a new pet health care division. , ... ... -- The pet health care division is designed to expand ...
Cached Medicine News:Health News:New Molecular Trigger Described for Hypertension, Diabetes 2Health News:New Molecular Trigger Described for Hypertension, Diabetes 3Health News: Virtualization with Dell Helps Cure Growing Health Care IT Ills 2Health News: Virtualization with Dell Helps Cure Growing Health Care IT Ills 3Health News: Virtualization with Dell Helps Cure Growing Health Care IT Ills 4Health News:4th Annual Dermatology Nurses' Association Summer Meeting to Arrive in Windy City 2Health News:American Heart Association Announces Fourth New Journal - Circulation: Cardiovascular Interventions to Debut in August 2Health News:American Heart Association Announces Fourth New Journal - Circulation: Cardiovascular Interventions to Debut in August 3Health News:American Heart Association Announces Fourth New Journal - Circulation: Cardiovascular Interventions to Debut in August 4Health News:Medline Announces Advanced Line of Therapeutic Mattresses, Operating Room Table Pads and Stretcher Pads 2Health News:Medline Announces Advanced Line of Therapeutic Mattresses, Operating Room Table Pads and Stretcher Pads 3Health News: University Health Industries Launches Natural Pet Health Care Division 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: